CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases

被引:69
|
作者
Lu, Qiang [1 ]
Cao, Wei [2 ]
Huang, Lijun [1 ]
Wan, Yi [3 ,4 ]
Liu, Tonggang [5 ]
Cheng, Qingshu [1 ]
Han, Yong [1 ]
Li, Xiaofei [1 ]
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Intervent Radiol, Xian 710032, Peoples R China
[3] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China
[4] Fourth Mil Med Univ, Inst Hlth Informat, Xian 710032, Peoples R China
[5] Fourth Mil Med Univ, Tangdu Hosp, Dept Resp, Xian 710032, Peoples R China
关键词
Percutaneous microwave coagulation therapy; Inoperable pulmonary malignancies; Survival rates; RADIOFREQUENCY ABLATION; LUNG MALIGNANCIES; FOLLOW-UP; THERAPY; RESECTION; CANCER; LIVER;
D O I
10.1186/1477-7819-10-80
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Microwave ablation (MWA) has attracted a worldwide attention gradually in treating inoperable pulmonary malignancies. However, in the lung tissues treated with MWA recurrence of tumor may still occur and few data in large patient groups till now were reported about the safety or effectiveness of microwave ablation in treating primary lung cancer and metastatic pulmonary malignancies. The purpose of this study is to evaluate the clinical curative effect (local control, survival data) MWA and its safety as well. Methods: From 1 January 2005 to 1 January 2008, retrospective analyses, 69 patients underwent computed tomography (CT)-guided percutaneous MWA of pulmonary malignancies. All patients were deemed medically inoperable. The correlation of tumor sizes and local progression after ablation was analyzed and the survival rates within 3 years post surgery were compared between non-small-cell lung cancer and pulmonary metastases groups also. Results: Pneumothorax was the most frequent complication and occurred in 24.64% patients after ablation. Neither needle track implantation was found nor did patient death occur in these patients within 30 days. The 1-, 2-, and 3-year overall survival rates were 66.7%, 44.9% and 24.6%, respectively. The overall survival rates for NSCLC patients in 1 year, 2 years, and 3 years were 75.0%, 54.2%, and 29.2%, respectively. The overall survival rates for pulmonary metastatic tumor patients in 1 year, 2 years, and 3 years were 47.6%, 23.8%, and 14.3%, respectively. The recurrence-free survival rates for NSCLC patients in 1 year, 2 years, and 3 years were 72.9%, 50.0%, and 27.1%, respectively. The mortality rates for pulmonary metastatic tumor patients in 1 year, 2 years, and 3 years were 47.6%, 19.0%, and 14.3%, respectively. Conclusions: Percutaneous microwave coagulation therapy was one safe and effective method and could be beneficial for the improvement of inoperable pulmonary malignancies treatment effect.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] CT-Guided Percutaneous Microwave Ablation of Tumors in the Hepatic Dome: Assessment of Efficacy and Safety
    Asvadi, Nazanin H.
    Anvari, Arash
    Uppot, Raul N.
    Thabet, Ashraf
    Zhu, Andrew X.
    Arellano, Ronald S.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 27 (04) : 496 - 502
  • [22] CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases
    Giron, J
    Poey, C
    Fajadet, P
    Sans, N
    Fourcade, D
    Senac, JP
    Railhac, JJ
    EUROPEAN JOURNAL OF RADIOLOGY, 1998, 28 (03) : 235 - 242
  • [23] CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 42 cases
    Giron, J
    Sans, N
    Poey, C
    Fajadet, P
    Fourcade, D
    Senac, JP
    Railhac, JJ
    JOURNAL DE RADIOLOGIE, 1998, 79 (02): : 139 - 145
  • [24] CT-guided percutaneous radiofrequency ablation of renal tumors
    Ogan, K
    Rivera, F
    Dolmatch, B
    Cadeddu, JA
    JOURNAL OF UROLOGY, 2002, 167 (04): : 16 - 16
  • [25] CT-guided percutaneous chemical ablation of adrenal neoplasms
    Xiao, Yue-Yong
    Tian, Jin-Lin
    Li, Jia-Kai
    Yang, Li
    Zhang, Jin-Shan
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (01) : 105 - 110
  • [26] CT-guided microwave ablation of hepatic malignancies via transpulmonary approach without ancillary techniques
    Raissi, Driss
    Sanampudi, Sreeja
    Yu, Qian
    Winkler, Michael
    JOURNAL OF CLINICAL IMAGING SCIENCE, 2022, 12 : 1 - 7
  • [27] Changes in the pulmonary function of CT-guided microwave ablation for patients with malignant lung tumors
    Li, Zhichao
    Zhao, Feng
    Wang, Gang
    Xue, Guoliang
    Wang, Nan
    Cao, Pikun
    Hu, Yanting
    Wei, Zhigang
    Ye, Xin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (06) : 1669 - 1674
  • [29] Percutaneous CT-Guided Microwave Ablation Combined with Vertebral Augmentation for Treatment of Painful Spinal Metastases
    Chen, L.
    Hou, G.
    Zhang, K.
    Li, Z.
    Yang, S.
    Qiu, Y.
    Yuan, Q.
    Hou, D.
    Ye, X.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2022, 43 (03) : 501 - 506
  • [30] Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation
    Zhong, Lou
    Sun, Siyuan
    Shi, Jiahai
    Cao, Fei
    Han, Xiao
    Bao, Xueping
    You, Qingsheng
    JOURNAL OF THORACIC DISEASE, 2017, 9 (03) : 590 - 597